⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11266465 | 0.78 | — | — | |
| SCHEMBL7483306 | 0.76 | — | — | |
| SCHEMBL6212505 | 0.70 | — | — | |
| SCHEMBL4078808 | 0.68 | — | — | |
| SCHEMBL28418210 | 0.65 | — | — | |
| SCHEMBL1962941 | 0.65 | — | — | |
| SCHEMBL921850 | 0.64 | — | — | |
| SCHEMBL8524652 | 0.63 | — | — | |
| SCHEMBL16179060 | 0.61 | — | — | |
| SCHEMBL1720840 | 0.60 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110337437-B | Substituted pyrazolopyrimidinones as PDE2 inhibitors | 达特神经科学有限公司 | 2023-02-03 | — | — | CN | claimed |
| CN-112513050-A | Heterocyclic compounds inhibiting SHP2 activity | 大鹏药品工业株式会社 | 2021-03-16 | — | — | CN | claimed |
| CN-107406451-B | Pyrrolopyrimidines and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors | 福马治疗股份有限公司 | 2019-12-17 | — | — | CN | claimed |
| EP-3240791-A1 | PYRROLO AND PYRAZOLOPYRIMIDINES AS UBIQUITIN-SPECIFIC PROTEASE 7 INHIBITORS | Forma Therapeutics, Inc. (US) | 2017-11-08 | — | — | EP | claimed |
| WO-2016109515-A1 | PYRROLO AND PYRAZOLOPYRIMIDINES AS UBIQUITIN-SPECIFIC PROTEASE 7 INHIBITORS | FORMA THERAPEUTICS, INC. (US) | 2016-07-07 | — | — | WO | claimed |
| US-20160185785-A1 | PYRROLO AND PYRAZOLOPYRIMIDINES AS UBIQUITIN-SPECIFIC PROTEASE 7 INHIBITORS | VALO HEALTH, INC. | 2016-06-30 | — | — | US | claimed |
| EP-2971086-A1 | FUNCTIONALIZED 3-ALKYNYL PYRAZOLOPYRIMIDINE ANALOGUES AS UNIVERSAL BASES AND METHODS OF USE | ELITechGroup B.V. (NL) | 2016-01-20 | — | — | EP | claimed |
| WO-2014159063-A1 | FUNCTIONALIZED 3-ALKYNYL PYRAZOLOPYRIMIDINE ANALOGUES AS UNIVERSAL BASES AND METHODS OF USE | ELITECH HOLDING B.V. (NL) | 2014-10-02 | — | — | WO | claimed |
| EP-2689031-A1 | FUNCTIONALIZED 3-ALKYNYL PYRAZOLOPYRIMIDINE ANALOGUES AS UNIVERSAL BASES AND METHODS OF USE | Elitech Holding B.V. (NL) | 2014-01-29 | — | — | EP | claimed |
| WO-2013048583-A2 | DETECTION OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS | ELITECH HOLDING B.V. (NL) | 2013-04-04 | — | — | WO | claimed |
| WO-2012129547-A1 | FUNCTIONALIZED 3-ALKYNYL PYRAZOLOPYRIMIDINE ANALOGUES AS UNIVERSAL BASES AND METHODS OF USE | ELITECH HOLDING B.V. (NL) | 2012-09-27 | — | — | WO | claimed |
| EP-1005471-B1 | PYRAZOLO(3,4-D)PYRIMIDINES WITH ANTICONVULSIVE AND ANTIALLERGIC/ANTIASTHMATIC ACTION | DRESDEN ARZNEIMITTEL (DE) | 2002-09-04 | — | — | EP | claimed |
| US-20250360137-A1 | ENHANCEMENT OF THE EFFICACY OF SEROTONERGIC PSYCHEDELIC DRUGS IN THE TREATMENT OR PREVENTION OF CERTAIN NEUROPSYCHIATRIC DISORDERS THROUGH INHIBITION OF TYPE-9 PHOSPHODIESTERASES | FREEDOM BIOSCIENCES INC (US) | 2025-11-27 | — | — | US | disclosed |
| EP-4618980-A1 | ENHANCEMENT OF THE EFFICACY OF SEROTONERGIC PSYCHEDELIC DRUGS IN THE TREATMENT OR PREVENTION OF CERTAIN NEUROPSYCHIATRIC DISORDERS THROUGH INHIBITION OF TYPE-9 PHOSPHODIESTERASES | Freedom Biosciences, Inc. (US) | 2025-09-24 | — | — | EP | disclosed |
| EP-4559520-A1 | NOVEL AQP4 INHIBITORS | Origenis GmbH (DE) | 2025-05-28 | — | — | EP | disclosed |
| US-12018030-B2 | Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors | VALO HEALTH, INC. (US) | 2024-06-25 | — | — | US | disclosed |
| US-6054460-A | Anticonvulsive and antiallergic/antiasthmatic pyrazolo-[3,4-d]pyrimidines, and process for preparing | ARZNEIMITTELWERK DRESDEN GMBH (DE) | 2000-04-25 | — | — | US | disclosed |
| US-6054460-A | Anticonvulsive and antiallergic/antiasthmatic pyrazolo-[3,4-d]pyrimidines, and process for preparing | ARZNEIMITTELWERK DRESDEN GMBH (DE) | 2000-04-25 | — | — | US | disclosed |
| WO-1999067243-A1 | PYRAZOLO(3,4-D)PYRIMIDINES WITH ANTICONVULSIVE AND ANTIALLERGIC/ANTIASTHMATIC ACTION | ARZNEIMITTELWERK DRESDEN GMBH (DE) | 1999-12-29 | — | — | WO | disclosed |
| WO-1999067243-A1 | PYRAZOLO(3,4-D)PYRIMIDINES WITH ANTICONVULSIVE AND ANTIALLERGIC/ANTIASTHMATIC ACTION | ARZNEIMITTELWERK DRESDEN GMBH (DE) | 1999-12-29 | — | — | WO | disclosed |